Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 USD | +0.96% |
|
-2.76% | -22.01% |
03/06 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
03/06 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.01% | 26Cr | |
+16.93% | 12TCr | |
+17.01% | 11TCr | |
-7.23% | 2.36TCr | |
+3.96% | 2.26TCr | |
-37.63% | 1.76TCr | |
-6.79% | 1.76TCr | |
-14.48% | 1.73TCr | |
+2.17% | 1.35TCr | |
+24.42% | 1.13TCr |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- Insider Sell: Uniqure